LD-2 disclosure · 1st Quarter - Termination
GENZYME CORPORATION
Client
- Location
- District of Columbia · United States of America
Registrant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
7 issuesCopyright/Patent/Trademark
Patent settlement legislation Preserve Access to Affordable Generics Act Creating and Restoring Equal Access to Equivalent Samples Act
LobbyistsSARA FROELICH · MELISSA BARTLETT
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Trade (domestic/foreign)
Trade legislation and other trade authority Protection and promotion of 12 years exclusivity for biologics Protection and promotion of Orphan Drug Act market exclusivity
LobbyistsSARA FROELICH · MELISSA BARTLETT
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Taxation/Internal Revenue Code
Implementation of Patient Protection & Affordable Health Care Act (P.L. 111-148) and Implementation of health Care and Education Reconciliation Act (P.L. 111-152) Excise tax for drugs and biologics Issues and policies related to Orphan Drug Tax Credit Implementation of American Taxpayer Relief Act of 2012 Issues and policies related to tax reform, including border adjustable tax Corporate tax inversion Legislation pertaining to the applicability of the ACA tax carve out for non-orphan designated drugs
